Baselight
Sign In
YesterdayMay 24May 23May 22May 21May 20May 19May 18May 17May 16May 15May 14May 13May 12May 11May 10May 9May 8May 7May 6May 5May 4May 3May 2May 1Apr 30Apr 29Apr 28Apr 27Apr 26Apr 24Apr 22Apr 21Apr 20Apr 19Apr 18Apr 17

Stocks

May 18, 2026

Inflection Point01STOCKS

Zebra Technologies surges 13.8% in two days after Q1 EPS beats by 11.8% and guidance raised

  • Zebra Technologies (ZBRA) reported Q1 adjusted EPS of $4.75, beating the $4.25 consensus by 11.8%, and raised its full-year 2026 adjusted EPS guidance above prior estimates
  • The stock climbed from $216.96 on May 11 to $246.76 by May 13 — a 13.8% two-day gain — with volume spiking to 2.88M shares on May 12 vs. a typical 1.4M average
  • Fourteen analysts now rate the stock a buy or strong buy (10 buy, 4 strong buy, 0 sell), with the FY 2026 EPS consensus at $18.40 — up 16.2% year-on-year
Zebra Technologies surges 13.8% in two days after Q1 EPS beats by 11.8% and guidance raised
Anomaly02STOCKS

Solara Active Pharma surges 14.2% on 37.9x average volume after Q4 record revenue

  • Solara Active Pharma Sciences (SOLARA.NS) gained 14.2% on May 14, closing at ₹579.90, as Q4 FY2026 earnings showed record revenue and EBITDA growth
  • Volume hit 4.01 million shares — 37.9x the 20-day average of 105,822 — reflecting elevated trading activity
  • The stock sits at ₹580 within a 52-week range of ₹422–₹734, recovering from near its annual low
Solara Active Pharma surges 14.2% on 37.9x average volume after Q4 record revenue
Divergence03STOCKS

Vedanta FY EPS consensus revised down 69% in 7 days; stock rises 11% post-demerger

  • Vedanta's (VEDL.NS) FY EPS consensus fell from ₹78.27 to ₹24.07 in seven days — a 69.2% revision — while the stock rose 11.1% from ₹298.40 to ₹331.05 between May 11 and May 14, coinciding with the May 1 demerger effective date.
  • The FY 2026 consensus is now ₹24.07 vs. a 30-day-ago figure of ₹75.05; 2 analyst cuts were recorded in seven days with zero upgrades; the demerger restructures earnings reporting across four separate entities.
  • At ₹331, the stock is 58.4% below its 52-week high of ₹795 and 23.2% above its 52-week low of ₹268.70.
Vedanta FY EPS consensus revised down 69% in 7 days; stock rises 11% post-demerger
Trend Shift04STOCKS

Whitbread absorbs 8 FY EPS cuts and 9 next-year cuts in 7 days, stock 30% below peak

  • Whitbread (WTB.L), the Premier Inn hotel operator, recorded 8 FY EPS cuts and 2 upgrades in the past seven days, plus 9 next-year EPS cuts with zero upgrades — a notably negative revision skew among UK consumer stocks in this snapshot
  • The stock closed at 2,302p on May 14, sitting 30.3% below its 52-week high of 3,302p and just 9.7% above its 52-week low of 2,098p
  • Despite the cuts, the current analyst distribution shows 6 buy and 1 strong buy vs. 3 strong sell — a split that reflects ongoing debate about the UK hotel sector's earnings trajectory
Whitbread absorbs 8 FY EPS cuts and 9 next-year cuts in 7 days, stock 30% below peak
Cross-Signal05STOCKS

Wipro CFO sold shares in early May as analysts split 18 upgrades vs 17 cuts; stock near 52-week low

  • Wipro's (WIPRO.NS) CFO sold 75,000 shares worth $159,000 in early May at ₹201.58 per share, as the stock trades near its 52-week low of ₹187
  • Analysts are almost perfectly split: 18 FY EPS upgrades vs. 17 cuts in the past seven days, with the overall rating distribution showing 17 hold, 13 buy/strong buy, and 13 sell/strong sell
  • The stock is 30.4% below its 52-week high of ₹273.10, with India IT sector headwinds — including OpenAI competition fears — continuing to weigh on the group
Wipro CFO sold shares in early May as analysts split 18 upgrades vs 17 cuts; stock near 52-week low

Share link

Anyone who has the link will be able to view this.